CN103041184A - 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 - Google Patents
用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103041184A CN103041184A CN2012105908625A CN201210590862A CN103041184A CN 103041184 A CN103041184 A CN 103041184A CN 2012105908625 A CN2012105908625 A CN 2012105908625A CN 201210590862 A CN201210590862 A CN 201210590862A CN 103041184 A CN103041184 A CN 103041184A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- herba
- radix
- medicine composition
- volatile oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 127
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims description 54
- 229940079593 drug Drugs 0.000 claims abstract description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 104
- 239000007788 liquid Substances 0.000 claims description 74
- 239000000341 volatile oil Substances 0.000 claims description 74
- 239000000706 filtrate Substances 0.000 claims description 62
- 238000005406 washing Methods 0.000 claims description 56
- 239000000843 powder Substances 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 239000012153 distilled water Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 23
- 239000009636 Huang Qi Substances 0.000 claims description 22
- 239000010231 banlangen Substances 0.000 claims description 21
- 241001533451 Ajuga ciliata Species 0.000 claims description 20
- 239000009670 cang er zi wan Substances 0.000 claims description 20
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 238000004821 distillation Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000002244 precipitate Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 238000003809 water extraction Methods 0.000 claims description 14
- 206010040882 skin lesion Diseases 0.000 claims description 13
- 231100000444 skin lesion Toxicity 0.000 claims description 13
- 238000001694 spray drying Methods 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 9
- -1 filter Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 54
- 208000003322 Coinfection Diseases 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 6
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000967218 Selaginella tamariscina Species 0.000 abstract 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 241001503991 Consolida Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000534017 Saururus chinensis Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 244000234281 Tamarix gallica Species 0.000 abstract 1
- 235000014265 Tamarix gallica Nutrition 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 45
- 210000004369 blood Anatomy 0.000 description 43
- 210000003491 skin Anatomy 0.000 description 31
- 210000000952 spleen Anatomy 0.000 description 26
- 208000010668 atopic eczema Diseases 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 19
- 208000003251 Pruritus Diseases 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 206010030113 Oedema Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 14
- 241000700199 Cavia porcellus Species 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 13
- 239000013641 positive control Substances 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 13
- 230000001154 acute effect Effects 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- 206010040943 Skin Ulcer Diseases 0.000 description 10
- 230000037396 body weight Effects 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 9
- 231100000019 skin ulcer Toxicity 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 206010014198 Eczema infantile Diseases 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- 230000007803 itching Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 5
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 229960000785 fluocinonide Drugs 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 210000004969 inflammatory cell Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000007937 eating Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 229960001660 histamine phosphate Drugs 0.000 description 3
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 206010000349 Acanthosis Diseases 0.000 description 2
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 2
- 206010052369 Encephalitis lethargica Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000669298 Pseudaulacaspis pentagona Species 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 201000002498 viral encephalitis Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 229940122739 Calcineurin inhibitor Drugs 0.000 description 1
- 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
- 101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000237955 Nassarius Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037868 Rash maculo-papular Diseases 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000003740 cowpox Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000008298 histiocytosis Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000021129 infant diet Nutrition 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 208000012965 maculopapular rash Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- BCSTWFQGKOAWED-HUCPNFHCSA-N pevisone Chemical compound O[N+]([O-])=O.C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1.C1CC2=CC(=O)C=C[C@]2(C)C2(F)[C@@H]1[C@@H]1C[C@@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O BCSTWFQGKOAWED-HUCPNFHCSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | n | 耳肿胀度(mg) |
模型对照组 | 20 | 7.15±1.16 |
阳性对照组 | 20 | 5.09±0.83 |
治疗组1 | 20 | 1.21±0.38 |
治疗组2 | 20 | 1.43±0.51 |
治疗组3 | 20 | 1.62±0.69 |
治疗组4 | 20 | 1.32±0.82 |
空白对照组 | 20 | 0.29±0.06 |
组别 | n | 痒阈值(μg) |
模型对照组 | 10 | 36.19±2.33 |
阳性对照组 | 10 | 69.58±2.81 |
治疗组5 | 10 | 134.26±3.01 |
治疗组6 | 10 | 111.96±2.37 |
治疗组7 | 10 | 116.89±3.61 |
治疗组8 | 10 | 126.51±2.73 |
组别 | 真皮内炎性细胞数(个/mm2) |
模型对照组 | 103.2±13.9 |
阳性对照组 | 48.1±9.6 |
治疗组9 | 29.1±4.1 |
治疗组10 | 34.1±6.3 |
治疗组11 | 38.6±3.8 |
治疗组12 | 32.1±4.7 |
组别 | n | 痊愈 | 显效 | 有效 | 无效 | 总有效率(%) |
治疗组 | 100 | 68 | 21 | 9 | 2 | 98.0 |
对照组 | 87 | 31 | 36 | 11 | 9 | 89.7 |
组别 | 痊愈数 | 复发数 | 复发率(%) |
治疗组 | 68 | 4 | 5.88 |
对照组 | 31 | 7 | 22.58 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590862.5A CN103041184B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590862.5A CN103041184B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041184A true CN103041184A (zh) | 2013-04-17 |
CN103041184B CN103041184B (zh) | 2014-05-07 |
Family
ID=48054195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210590862.5A Expired - Fee Related CN103041184B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041184B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417720A (zh) * | 2013-08-05 | 2013-12-04 | 谢明臣 | 治疗婴儿湿疹的中药组合物 |
CN103536806A (zh) * | 2013-11-09 | 2014-01-29 | 王墨茹 | 一种治疗酒精性心肌病的药物组合物 |
CN103550587A (zh) * | 2013-11-09 | 2014-02-05 | 邹建峰 | 一种治疗酒精性心肌病胶囊及其制备方法 |
CN103550586A (zh) * | 2013-11-09 | 2014-02-05 | 孙明慧 | 一种治疗酒精性心肌病心律失常颗粒剂及其制备方法 |
CN104491449A (zh) * | 2014-12-25 | 2015-04-08 | 刘永振 | 一种治疗小儿湿疹的中药外洗剂 |
CN105031223A (zh) * | 2015-08-31 | 2015-11-11 | 王学宽 | 一种治疗外耳湿疹的中西药复方制剂 |
CN105079651A (zh) * | 2015-07-30 | 2015-11-25 | 舒双平 | 一种用于治疗幼儿秋季皮肤瘙痒的中药组合物 |
CN110954645A (zh) * | 2019-09-09 | 2020-04-03 | 山东琪康生物技术有限公司 | 一种高质量四黄止痢颗粒的检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101804166A (zh) * | 2010-05-05 | 2010-08-18 | 余静 | 一种治疗小儿皮炎湿疹的中药组合物 |
CN101904855A (zh) * | 2009-06-05 | 2010-12-08 | 李文化 | 抗敏杀菌联合针剂 |
CN102266486A (zh) * | 2011-07-27 | 2011-12-07 | 陈忠和 | 脱敏消疹除疮的药物 |
-
2012
- 2012-12-29 CN CN201210590862.5A patent/CN103041184B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101904855A (zh) * | 2009-06-05 | 2010-12-08 | 李文化 | 抗敏杀菌联合针剂 |
CN101804166A (zh) * | 2010-05-05 | 2010-08-18 | 余静 | 一种治疗小儿皮炎湿疹的中药组合物 |
CN102266486A (zh) * | 2011-07-27 | 2011-12-07 | 陈忠和 | 脱敏消疹除疮的药物 |
Non-Patent Citations (1)
Title |
---|
武学文等: "三元医学的中药分类浅论", 《光明中医》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417720A (zh) * | 2013-08-05 | 2013-12-04 | 谢明臣 | 治疗婴儿湿疹的中药组合物 |
CN103536806A (zh) * | 2013-11-09 | 2014-01-29 | 王墨茹 | 一种治疗酒精性心肌病的药物组合物 |
CN103550587A (zh) * | 2013-11-09 | 2014-02-05 | 邹建峰 | 一种治疗酒精性心肌病胶囊及其制备方法 |
CN103550586A (zh) * | 2013-11-09 | 2014-02-05 | 孙明慧 | 一种治疗酒精性心肌病心律失常颗粒剂及其制备方法 |
CN103550587B (zh) * | 2013-11-09 | 2015-06-10 | 邹建峰 | 一种治疗酒精性心肌病胶囊及其制备方法 |
CN103550586B (zh) * | 2013-11-09 | 2015-06-17 | 孙明慧 | 一种治疗酒精性心肌病心律失常颗粒剂及其制备方法 |
CN104491449A (zh) * | 2014-12-25 | 2015-04-08 | 刘永振 | 一种治疗小儿湿疹的中药外洗剂 |
CN105079651A (zh) * | 2015-07-30 | 2015-11-25 | 舒双平 | 一种用于治疗幼儿秋季皮肤瘙痒的中药组合物 |
CN105031223A (zh) * | 2015-08-31 | 2015-11-11 | 王学宽 | 一种治疗外耳湿疹的中西药复方制剂 |
CN110954645A (zh) * | 2019-09-09 | 2020-04-03 | 山东琪康生物技术有限公司 | 一种高质量四黄止痢颗粒的检测方法 |
CN110954645B (zh) * | 2019-09-09 | 2020-09-29 | 山东琪康生物技术有限公司 | 一种高质量四黄止痢颗粒的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103041184B (zh) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041184B (zh) | 用于治疗婴幼儿慢性湿疹的中药组合物及其制备方法 | |
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN103041173A (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN104784673B (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN103690919A (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102178818B (zh) | 一种治疗乳腺癌的中药组合物及其制备方法 | |
CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
CN103652490B (zh) | 用于治疗猪蓝耳病的猪饲料及其制备方法 | |
CN105213807A (zh) | 用于治疗阴虚火旺型复发性口腔溃疡的药物 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN103028060A (zh) | 用于治疗婴幼儿急性湿疹的中药组合物及其制备方法 | |
CN103055218A (zh) | 用于治疗新生儿黄疸的中药组合物及其制备方法 | |
CN103041194B (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN103041161B (zh) | 用于治疗急性湿疹的内服中药组合物及其制备方法 | |
CN103721191A (zh) | 一种治疗妇女慢性盆腔炎的中药灌肠剂及其制备方法 | |
CN103623192B (zh) | 用于治疗猪蓝耳病的药物及其制备方法 | |
CN103007145A (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN102600388B (zh) | 一种治疗牲畜胎动不安的中草药组合物 | |
CN105726789A (zh) | 一种用于治疗褥疮的护理药物制剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ren Jian Inventor after: Liu Bingtian Inventor after: Wu Dajun Inventor after: Han Min Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: REN JIAN LIU BINGTIAN WU DAJUN HAN MIN |
|
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Patentee before: Qingdao Hengbo Instrument Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180327 Address after: 401120 Chongqing Yubei District Hui Xing Street Xingke Road No. 293 with mountain name 7 9 Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20181229 |